Henry Schein Stock Fair Value – HENRY SCHEIN Reports 3.1% Revenue Increase for Q3 of 2023

☀️Earnings Overview

For the quarter ending on September 30, 2023, HENRY SCHEIN ($NASDAQ:HSIC) reported total revenue of USD 3162.0 million, a 3.1% growth compared to the same quarter in 2022. Net income for the quarter was USD 137.0 million, an 8.7% decrease from the same period in the prior year.

Analysis – Henry Schein Stock Fair Value

GoodWhale has analyzed the financials of HENRY SCHEIN and determined the intrinsic value of its share to be around $82.1. This was calculated by our proprietary Valuation Line, which takes into account many factors such as projected growth rate, earnings per share, debt-to-equity ratio, and more. At the moment, HENRY SCHEIN stock is trading at $67.5 a share, which is a fair price but is slightly undervalued by 17.8%. This could present an opportunity for investors to acquire the stock at a discounted rate. The company has shown strong financial performance in recent years and has a diversified portfolio of products and services, so it is a worthwhile investment for those looking for long term growth and stability. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Henry Schein. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Henry Schein. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Henry Schein. More…

Key Ratios Snapshot

Some of the financial key ratios for Henry Schein are shown below. More…

Peers

Henry Schein Inc is one of the largest companies in the dental supplies industry.

However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.

– Healthlead PCL ($SET:HL)

LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.

– Patterson Companies Inc ($NASDAQ:PDCO)

Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.

– Alfresa Holdings Corp ($TSE:2784)

Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.

Summary

Henry Schein reported total revenue of USD 3162.0 million for the quarter ending September 30, 2023, representing a 3.1% year-over-year increase. Despite this, net income was 8.7% lower than the corresponding period in 2023, coming in at USD 137.0 million. Stock prices rose on the news, indicating that investors remain optimistic about the company’s performance in the future. In light of this, Henry Schein may be a viable investment opportunity given its strong revenue growth and potential for growth in the coming quarters.